tiprankstipranks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market

Cartesian Therapeutics (RNAC) Ownership - Who Owns Cartesian Therapeutics?

Compare
1,104 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 15, 2025
Timothy A Springer
Director, >10% Owner
xxxxxxxxxxxxx
$366273
Jan 07, 2025
xxxxxxxxxxxxx
$42777
Jan 07, 2025
xxxxxxxxxxxxx
$81780
Jan 07, 2025
Carsten Brunn
President & Ceo,director
xxxxxxxxxxxxx
$289729

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,391,955Insider36.51%184,739,755
5,064,237Insider19.69%99,613,542
5,061,637Insider19.68%99,562,400
1,184,346Institution4.60%23,296,086
728,401Insider2.83%14,327,648
538,853Institution2.09%10,599,239
511,159Institution1.99%10,054,498
456,372Institution1.77%8,976,837
400,679Institution1.56%7,881,356
398,204Institution1.55%7,832,673

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,184,346Institution4.60%23,296,086
538,853Institution2.09%10,599,239
511,159Institution1.99%10,054,498
398,204Institution1.55%7,832,673
183,168Institution0.71%3,602,915
121,318Institution0.47%2,386,325
85,524Institution0.33%1,682,257
78,265Institution0.30%1,539,473
46,809Institution0.18%920,733
41,109Institution0.16%808,614

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
258,985Institution1.01%5,094,235
242,132Institution0.94%43,584
202,634Institution0.79%3,629,175
139,313Institution0.54%2,495,096
90,359Institution0.35%1,777,362
57,434Institution0.22%1,129,727
48,724Institution0.19%872,647
27,325Institution0.11%4,919
23,853Institution0.09%469,189
20,055Institution0.08%381,647

FAQ

Who Owns Cartesian Therapeutics (RNAC)?
Currently, no data Available
What percentage of Cartesian Therapeutics (RNAC) stock is held by institutional investors?
Currently, no data Available
What percentage of Cartesian Therapeutics (RNAC) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cartesian Therapeutics (RNAC)?
TIMOTHY A SPRINGER owns the most shares of Cartesian Therapeutics (RNAC).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis